CARIPRAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Cariprazine Hydrochloride patents expire, and what generic alternatives are available?
Cariprazine Hydrochloride is a drug marketed by Sun Pharm and Zydus and is included in two NDAs.
The generic ingredient in CARIPRAZINE HYDROCHLORIDE is cariprazine hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cariprazine hydrochloride profile page.
Summary for CARIPRAZINE HYDROCHLORIDE
Recent Clinical Trials for CARIPRAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Medical Research Network | Phase 4 |
AbbVie | Phase 4 |
AbbVie | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for CARIPRAZINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for CARIPRAZINE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VRAYLAR | Capsules | cariprazine hydrochloride | 1.5 mg, 3 mg, 4.5 mg and 6 mg | 204370 | 3 | 2019-09-17 |